Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy

Frederick L Locke; Marco L Davila

doi:10.1080/14712598.2017.1322953

Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy

Expert Opin Biol Ther. 2017 Jun;17(6):659-661. doi: 10.1080/14712598.2017.1322953.

Authors

Frederick L Locke^{1

2}, Marco L Davila^{1

2}

Affiliations

¹ a Department of Blood and Marrow Transplant and Cellular Immunotherapy , H. Lee Moffitt Cancer Center and Research Institute , Tampa , FL , USA.
² b Department of Oncologic Sciences, Morsani College of Medicine , University of South Florida , Tampa , FL , USA.

PMID: 28454503
DOI: 10.1080/14712598.2017.1322953

No abstract available

Keywords: B cell acute lymphoblastic leukemia; Immunotherapy; adoptive T cell therapy; chimeric antigen receptor; diffuse large B cell lymphoma; gene therapy.

Publication types

Editorial